Reply to Letter on: Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia 36-Month Results From the European SOHO Study

被引：0
|
作者：
Novick, Diego [1 ,2 ]
Maria Haro, Joseph
Bertsch, Jordan
Haddad, Peter M.
机构：
[1] Eli Lilly & Co, Surrey, England
[2] Univ Autonoma Barcelona, Dept Psiquiatria, Barcelona, Spain
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2011年 / 31卷 / 03期
关键词：
D O I：
10.1097/JCP.0b013e3182192c1d
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [21] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Hong, Jihyung
    Novick, Diego
    Brugnoli, Roberto
    Karagianis, Jamie
    Dossenbach, Martin
    Haro, Josep Maria
    BMC PSYCHIATRY, 2012, 12
  • [22] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Jihyung Hong
    Diego Novick
    Roberto Brugnoli
    Jamie Karagianis
    Martin Dossenbach
    Josep Maria Haro
    BMC Psychiatry, 12
  • [23] Factors associated to risk of relapse in schizophrenia: 36 month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D
    Haro, JM
    Suarez, D
    Ratcliffe, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 60 - 60
  • [24] Frequency of response and relapse across different geographical regions: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Novick, D.
    Haro, J. M.
    Brugnoli, R.
    Jordan, B.
    Hong, J.
    Jamie, K.
    Dossenbach, M.
    Alvarez, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 231 - 231
  • [25] Combined Effects of Pain Interference and Depressive Symptoms on Dementia Incidence: A 36-Month Follow-Up Study
    Makino, Keitaro
    Lee, Sangyoon
    Bae, Seongryu
    Shinkai, Yohei
    Chiba, Ippei
    Shimada, Hiroyuki
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (02) : 703 - 712
  • [26] Adaptation of the 36-month Ages and Stages Questionnaire in Taiwan: Results from a preliminary study
    Tsai, Huei-Ling Agnes
    McClelland, Megan M.
    Pratt, Clara
    Squires, Jane
    JOURNAL OF EARLY INTERVENTION, 2006, 28 (03) : 213 - 225
  • [27] The European Schizophrenia Outpatient Health Outcomes Study: Effectiveness results of the French cohort of schizophrenic outpatients over a 36-month follow-up
    Gasquet, I.
    Chartier, F.
    Tcherny-Lessenot, S.
    Lepine, J. -P
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2009, 57 (01): : 25 - 32
  • [28] Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions
    Szafranski, Tomasz
    PSYCHIATRIA POLSKA, 2014, 48 (06) : 1155 - 1165
  • [29] Extrapyramidal symptoms among patients with schizophrenia treated with olanzapine or other antipsychotics: 6-month results of the Intercontinental Schizophrenia Outpatient Health Outcomes study - IC-SOHO (Polish sample)
    Debowska, G
    Meder, J
    Lis, J
    Szulc, A
    EUROPEAN PSYCHIATRY, 2004, 19 : 173S - 173S
  • [30] Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: Results from veterans affairs cooperative study 394
    Lohr, JB
    Caligiuri, MP
    Edson, R
    Lavori, P
    Adler, LA
    Rotrosen, J
    Hitzemann, R
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 196 - 200
12345